Inicio >> Signaling Pathways >> Tyrosine Kinase >> Ephrin Receptor

Ephrin Receptor

Ephrin receptors (Ephs) are a group of receptors that are activated in response to binding ephrin. Ephs form the largest known subfamily of receptor tyrosine kinases (RTKs). Both Ephs and their corresponding ephrin ligands are membrane-bound proteins that require direct cell-cell interactions for Eph receptor activation. Eph/ephrin signaling has been implicated in the regulation of a host of processes critical to embryonic development including axon guidance, formation of tissue boundaries, cell migration, and segmentation. Additionally, Eph/epherin signaling has recently been identified to play a critical role in the maintenance of several processes during adulthood including long-term potentiation, angiogenesis, and stem cell differentiation and cancer. The ability of Ephs and ephrins to mediate a variety of cell-cell interactions places the Eph/ephrin system in an ideal position to regulate a variety of different biological processes during embryonic development.

Targets for  Ephrin Receptor

Products for  Ephrin Receptor

  1. Cat.No. Nombre del producto Información
  2. GC35053 123C4 123C4 es un agonista potente, selectivo y competitivo del receptor tirosina quinasa EPHA4, con un valor Ki de 0,65 μM. 123C4  Chemical Structure
  3. GC11134 ALW-II-41-27

    Eph receptor tyrosine kinase inhibitor;

    Un inhibidor de múltiples quinasas.

    ALW-II-41-27  Chemical Structure
  4. GC68647 ALW-II-49-7

    ALW-II-49-7 es un inhibidor selectivo de EphB2 con una EC50 intracelular de 40 nM.

    ALW-II-49-7  Chemical Structure
  5. GC25367 Ehp-inhibitor-1

    Ehp inhibitor 2

    Ehp-inhibitor-1 (Ehp inhibitor 2) is an Eph family tyrosine kinase inhibitor that targets Eph receptors. Ehp-inhibitor-1  Chemical Structure
  6. GC69258 Ifabotuzumab

    KB004

    Ifabotuzumab (KB004) is an IgG1κ antibody that targets EphA3 (KD=610 pM). Ifabotuzumab can induce apoptosis in tumor cells and activate antibody-dependent cell-mediated cytotoxicity (ADCC), destroying the tumor vascular system. Ifabotuzumab can reduce CCR10+ cells in idiopathic pulmonary fibrosis (IPF) patients, improving lung fibrosis.

    Ifabotuzumab  Chemical Structure
  7. GC18168 JI-101

    CGI1842

    JI-101 es un inhibidor multicinasa disponible por vÍa oral de VEGFR2, PDGFRβ y EphB4 con una potente actividad anticancerÍgena. JI-101  Chemical Structure
  8. GC50137 KYL KYL, un péptido antagonista, se dirige selectivamente al receptor EphA4. KYL  Chemical Structure
  9. GC14332 NVP-BHG712 NVP-BHG712 es un inhibidor de la autofosforilaciÓn de la cinasa EphB4 activo por vÍa oral, con valores IC50 de 3,3 nM y 3,0 nM para EphA2 y EphB4, respectivamente. NVP-BHG712  Chemical Structure
  10. GC36782 NVP-BHG712 isomer El isÓmero NVP-BHG712, un regioisÓmero de NVP-BHG712, muestra una uniÓn no enlazada conservada a EPHA2 y EPHB4. NVP-BHG712 isomer  Chemical Structure
  11. GC74367 Targefrin Targefrin es un potente agente epha2, actúa como un antagonista. Targefrin  Chemical Structure
  12. GC31752 Tesevatinib (XL-647)

    EXEL-7647, Tesevatinib

    Tesevatinib (XL-647) (XL-647; EXEL-7647; KD-019) es un inhibidor de la tirosina cinasa multidiana disponible por vÍa oral; inhibe la cinasa EGFR, ErbB2, KDR, Flt4 y EphB4 con IC50 de 0,3, 16, 1,5, 8,7 y 1,4 nM. Tesevatinib (XL-647)  Chemical Structure
  13. GC64856 UniPR129 UniPR129 es un potente antagonista de Eph/ephrin. UniPR129 tiene el potencial para la investigaciÓn de la enfermedad del cÁncer. UniPR129  Chemical Structure
  14. GC70097 Urolithin D

    Urolithin D es un antagonista competitivo y reversible del receptor EphA. Urolithin D muestra selectividad intraclase.

    Urolithin D  Chemical Structure

13 artículo(s)

por página

Fijar Dirección Descendente